Tactile Systems Technology 경영진
경영진 기준 점검 2/4
Tactile Systems Technology CEO는 Sheri Dodd, Jul2024 에 임명되었습니다 의 임기는 1.83 년입니다. 총 연간 보상은 $3.47M, 19.5% 급여 및 80.5% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $1.83M 가치에 해당하는 회사 주식의 0.35% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 2.5 년과 3.8 년입니다.
핵심 정보
Sheri Dodd
최고경영자
US$3.5m
총 보수
| CEO 급여 비율 | 19.47% |
| CEO 재임 기간 | 1.8yrs |
| CEO 지분 보유율 | 0.4% |
| 경영진 평균 재임 기간 | 2.5yrs |
| 이사회 평균 재임 기간 | 3.8yrs |
최근 경영진 업데이트
Recent updates
TCMD: Lymphedema Execution And Multi Year Guidance Will Support Continued Upside
Analysts have lifted the consolidated price target for Tactile Systems Technology to around $38, supported by higher projections for revenue growth, improved profit margins, and a lower assumed future P/E multiple following recent Q4 upside and updated multi year guidance. Analyst Commentary Recent Street research on Tactile Systems Technology highlights a range of views on execution, growth prospects, and valuation following the Q4 results and updated multi year guidance.Should You Think About Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD) Now?
Apr 18
TCMD: Lymphedema Momentum And Q4 Execution Will Drive Multi Year Upside
The updated analyst price target for Tactile Systems Technology has been set at $38. This reflects analysts' reactions to recent Q4 outperformance, higher long-term estimates, and ongoing attention to productivity, patient referrals, and the lymphedema business.TCMD: Lymphedema Momentum And Q4 Execution Will Support Multi Year Upside
Analysts have lifted the consolidated price target for Tactile Systems Technology to $38, reflecting a series of Street target increases into the $32 to $42 range, supported by recent Q4 outperformance, updated multi year guidance, and progress in productivity and cost controls. Analyst Commentary Street commentary around Tactile Systems Technology is mixed, with several bullish analysts lifting targets on the back of Q4 execution and longer term guidance, while more cautious voices question how much upside remains after the post earnings re rating.TCMD: Lymphedema Momentum And Q4 Execution Will Support Ongoing Upside Potential
Analysts have nudged their average price target for Tactile Systems Technology to $38. This reflects stronger recent Q4 execution, raised long term estimates and ongoing improvements in productivity, patient referrals and cost controls.TCMD: Lymphedema Momentum And Q4 Execution Will Support Measured Turnaround Expectations
The analyst fair value estimate for Tactile Systems Technology has been raised from $29.75 to $38.00, reflecting higher Street price targets in the $32 to $42 range as analysts cite recent Q4 upside, improved productivity and cost controls, and ongoing strength in the lymphedema business. Analyst Commentary Street research on Tactile Systems Technology is generally constructive, with higher fair value assumptions linked to recent Q4 performance, execution on productivity and cost controls, and expectations around the lymphedema business.TCMD: Index Inclusion And Stable Outlook Will Shape Measured Turnaround Expectations
Analysts have maintained their fair value estimate for Tactile Systems Technology at $29.75 per share. They cited only very small adjustments to assumptions regarding the discount rate, revenue growth, profit margins, and future P/E multiples, rather than any change in the core outlook.TCMD: Turnaround Momentum And Buyback Will Test Q3 Outperformance Sustainability
Analysts have raised their price targets on Tactile Systems Technology to a roughly mid to high $20s to low $30s range, citing stronger than expected Q3 results, improved productivity, sales force expansion, new products, and better reimbursement trends that together support a higher fair value assessment. Analyst Commentary Recent research points to a more constructive view on Tactile Systems Technology following its Q3 outperformance, with several firms raising price targets and upgrading ratings based on execution and perceived upside to fair value.TCMD: Q3 Turnaround Momentum And Buyback Will Face Execution Risk
Analysts have raised their price target on Tactile Systems Technology to about $29.75 from $24, citing stronger recent earnings performance, expectations for operational improvements, and support for a higher future P/E multiple. Analyst Commentary Recent research updates on Tactile Systems Technology highlight a clear shift toward a more constructive stance, with multiple firms lifting price targets after Q3 results and pointing to both execution progress and valuation support.Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 28%
Dec 18TCMD: Q3 Outperformance And Buyback Will Mask Limited Upside Ahead
Analysts have raised their price target on Tactile Systems Technology by about $8.50 to roughly $32 per share, citing significant Q3 outperformance, improving productivity and reimbursement trends, and expectations for a return to double digit growth by 2026. Analyst Commentary Recent research updates reflect a notably more constructive stance on Tactile Systems Technology, with bullish analysts pointing to operational momentum, clearer reimbursement visibility, and a sizable underpenetrated patient pool as key drivers of potential upside in the shares.TCMD: Q3 Outperformance And Buyback Plan Will Shape Turnaround Outlook
Analysts have raised their price expectations for Tactile Systems Technology toward the low to mid $30 range, citing a massive Q3 outperformance, consistent estimate beats, and growing confidence in a 2026 growth reacceleration and higher sustainable earnings power. Analyst Commentary Recent Street research reflects a broadly constructive stance on Tactile Systems Technology following its strong Q3 performance and improving fundamentals.TCMD: Sustained Product Execution And Buyback Plan Set To Shape Outlook
Analysts have raised their price target on Tactile Systems Technology significantly, from approximately $16.83 to $24.00. They cite strong quarterly outperformance and growing confidence in the company’s turnaround and future growth prospects.Results: Tactile Systems Technology, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Nov 06TCMD: Market Leadership And Coverage Momentum Will Drive Expansion Into Underserved Patients
Narrative Update on Tactile Systems Technology Analysts have reaffirmed their price target for Tactile Systems Technology at $16.83 per share. They cite the company's leadership in key market segments and anticipated growth acceleration as a result of recent strategic improvements.At-home Healthcare And Workflow Automation Will Expand Patient Reach
Analysts have maintained their price target for Tactile Systems Technology at $23.50. They cite the company's leading positions in key device markets and an improved outlook following recent strategic adjustments.At-home Healthcare And Workflow Automation Will Expand Patient Reach
Analysts have raised their fair value estimate for Tactile Systems Technology from $13.50 to $16.83 per share. The change is attributed to optimism about the company's strengthened market leadership and the potential for renewed growth following recent strategic improvements.When Should You Buy Tactile Systems Technology, Inc. (NASDAQ:TCMD)?
Oct 04Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Shares Leap 28% Yet They're Still Not Telling The Full Story
Aug 29Tactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture
May 12Slammed 28% Tactile Systems Technology, Inc. (NASDAQ:TCMD) Screens Well Here But There Might Be A Catch
May 08Why Tactile Systems Technology, Inc. (NASDAQ:TCMD) Could Be Worth Watching
May 07Tactile Systems Technology: Interesting Devices Company, Need More Clarity
Apr 07Tactile Systems Technology (NASDAQ:TCMD) Has A Rock Solid Balance Sheet
Feb 23Investors Appear Satisfied With Tactile Systems Technology, Inc.'s (NASDAQ:TCMD) Prospects As Shares Rocket 26%
Nov 25Tactile Systems Technology, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07
Nimbl Approval And Tech Investments Propel Growth Amid Shrinking Margins And Operational Risks
Investments in technology and workflow improvements, alongside FDA approval for Nimbl, indicate a strong focus on innovation and market expansion.Investors Holding Back On Tactile Systems Technology, Inc. (NASDAQ:TCMD)
Jul 17US$20.67: That's What Analysts Think Tactile Systems Technology, Inc. (NASDAQ:TCMD) Is Worth After Its Latest Results
May 09Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 23Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?
Oct 10Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal
Sep 16Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?
Jul 13Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?
May 10Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?
Feb 16CEO 보수 분석
| 날짜 | 총 보수 | 급여 | 회사 수익 |
|---|---|---|---|
| Dec 31 2025 | US$3m | US$675k | US$19m |
| Sep 30 2025 | n/a | n/a | US$18m |
| Jun 30 2025 | n/a | n/a | US$15m |
| Mar 31 2025 | n/a | n/a | US$16m |
| Dec 31 2024 | US$1m | US$330k | US$17m |
| Sep 30 2024 | n/a | n/a | US$15m |
| Jun 30 2024 | n/a | n/a | US$33m |
| Mar 31 2024 | n/a | n/a | US$28m |
| Dec 31 2023 | US$209k | n/a | US$29m |
| Sep 30 2023 | n/a | n/a | US$25m |
| Jun 30 2023 | n/a | n/a | US$356k |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | US$211k | n/a | -US$18m |
| Sep 30 2022 | n/a | n/a | -US$30m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$25m |
| Dec 31 2021 | US$232k | n/a | -US$12m |
보상 대 시장: Sheri의 총 보수(USD3.47M)는 US 시장에서 비슷한 규모 기업의 평균(USD2.57M)보다 높습니다.
보상과 수익: Sheri의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Sheri Dodd (59 yo)
1.8yrs
재임 기간
US$3,466,916
보수
Ms. Sheri Louise Dodd serves as Chief Executive Officer, President & Director of Tactile Systems Technology, Inc. since July 01, 2024 and served as its Independent Director since January 01, 2021 until Jul...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO, President & Director | 1.8yrs | US$3.47m | 0.35% $ 1.8m | |
| Chief Financial Officer | 3.2yrs | US$1.89m | 0.23% $ 1.2m | |
| Senior Vice President of Business Development | less than a year | US$1.16m | 0.20% $ 1.1m | |
| Senior Vice President of Manufacturing | no data | 데이터 없음 | 데이터 없음 | |
| Chief Information Officer | 3.1yrs | 데이터 없음 | 데이터 없음 | |
| VP of Regulatory Affairs & Chief Compliance Officer | no data | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Sales | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Marketing & Market Access | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Human Resource Officer | 4.3yrs | 데이터 없음 | 데이터 없음 | |
| Chief Medical Officer & Member of Vascular Strategic Advisory Board | 3.3yrs | 데이터 없음 | 데이터 없음 |
2.5yrs
평균 재임 기간
53yo
평균 나이
경험이 풍부한 관리: TCMD의 경영진은 경험이 있음으로 간주됩니다(평균 재임 2.5 년).
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO, President & Director | 5.3yrs | US$3.47m | 0.35% $ 1.8m | |
| Chief Medical Officer & Member of Vascular Strategic Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 3.3yrs | US$232.49k | 0.095% $ 494.9k | |
| Independent Director | 8.7yrs | US$224.99k | 0.18% $ 921.1k | |
| Independent Chairman | 10.7yrs | US$264.99k | 0.14% $ 742.6k | |
| Independent Director | 4.3yrs | US$222.49k | 0.14% $ 749.5k | |
| Independent Director | 1.3yrs | US$219.99k | 0.013% $ 68.0k | |
| Independent Director | less than a year | 데이터 없음 | 0% $ 0 | |
| Member of Vascular Strategic Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Vascular Strategic Advisory Board | 2.3yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 2.6yrs | US$219.99k | 0.084% $ 438.8k | |
| Independent Director | 4.3yrs | US$224.99k | 0.14% $ 749.5k |
3.8yrs
평균 재임 기간
64yo
평균 나이
경험이 풍부한 이사회: TCMD의 이사회는 경험이 있음으로 간주됩니다(평균 재임 3.8 년).
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/04 05:21 |
| 종가 | 2026/05/04 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Tactile Systems Technology, Inc.는 12명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| null null | Argus Research Company |
| Kyle Bauser | B. Riley Securities, Inc. |
| Anderson Schock | B. Riley Securities, Inc. |